These data show that cyclin–CDK1 complexes play an important role in facilitating invasive migration in both ovarian and bladder cancer cells, and that changes in expression of CDK1 and partner cyclins might contribute to the acquirement of an invasive phenotype in BC cells. Here, CDK1 is linked to breast cancer.